XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - USD ($) $ in Thousands		1 Months Ended		3 Months Ended
	Nov. 15, 2021	Mar. 31, 2023	Feb. 28, 2023	Mar. 31, 2024	Mar. 31, 2023	Jan. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Settled liability					$ 365
(Gain) loss on fair value remeasurement of deferred purchase consideration					(230)
Contingent milestone consideration paid in shares value					2,354
Loss (gain) on fair value remeasurement of contingent consideration				$ (158)	$ (1,847)
Change in fair value of deferred purchase consideration				0
Combangio, Inc.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Number of shares	155,664
Combangio, Inc. | Shares Issued on January 3, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Number of shares	136,314
Combangio, Inc. | Shares not issued until escrow release date of March 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Number of shares	19,350
Combangio, Inc. | First patient dosed with any product in phase 2 clinical trial, dosing milestone
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Contingent milestone consideration						$ 146
Contingent milestone consideration paid			$ 2,500	2,646
Contingent milestone consideration paid in shares value			$ 2,354	$ 2,354
Contingent milestone consideration paid in shares		105,038		105,038
Combangio, Inc. | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Contingent milestone consideration	$ 105,000

X

- Definition

Number of shares of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.

+ References

No definition available.

+ Details

Name:	kala_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableNumberOfShares
Namespace Prefix:	kala_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of contingent milestone consideration payable in cash in connection with asset acquisition.

+ References

No definition available.

+ Details

Name:	kala_AssetAcquisitionContingentMilestoneConsiderationCashPaid
Namespace Prefix:	kala_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Amount of acquirer's equity interest issued and issuable as part of contingent milestone consideration transferred in asset acquisition.

+ References

No definition available.

+ Details

Name:	kala_AssetAcquisitionContingentMilestoneConsiderationEquityInterestIssuedOrIssuable
Namespace Prefix:	kala_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Number of shares of acquirer's equity interest issued and issuable as part of contingent milestone consideration transferred in asset acquisition.

+ References

No definition available.

+ Details

Name:	kala_AssetAcquisitionContingentMilestoneConsiderationNumberOfEquityInterestIssuedOrIssuable
Namespace Prefix:	kala_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of contingent milestone consideration in connection with asset acquisition.

+ References

No definition available.

+ Details

Name:	kala_AssetAcquisitionContingentMilestoneConsiderationPayable
Namespace Prefix:	kala_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Amount of (gain) loss recognized on fair value adjustment of contingent consideration.

+ References

No definition available.

+ Details

Name:	kala_GainLossOnFairValueReMeasurementOfContingentConsideration
Namespace Prefix:	kala_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Amount of gain (loss) recognized on fair value adjustment of deferred purchase consideration.

+ References

No definition available.

+ Details

Name:	kala_GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
Namespace Prefix:	kala_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482106/820-10-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482106/820-10-50-3

+ Details

Name:	us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482106/820-10-50-2

+ Details

Name:	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482106/820-10-50-2

+ Details

Name:	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	us-gaap_AssetAcquisitionAxis=kala_CombangioIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementScenarioAxis=kala_SharesIssuedOnJanuary32022Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementScenarioAxis=kala_SharesNotIssuedUntilEscrowReleaseDateOfMarch2023Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementScenarioAxis=kala_FirstPatientDosedWithAnyProductInPhase2ClinicalTrialDosingMilestoneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: